A primer on fen-phen litigation: allegations and defenses

The diet drug known as Fen-Phen was recently implicated as a cause of valvular heart disease in women. Fen-Phen is a combination of Fenfluramine and Phentermine, 2 commonly prescribed appetite suppressants. Both drugs were approved by the FDA for the short-term management of obesity. However, the FD...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Defense counsel journal 1998-07, Vol.65 (3), p.353
Hauptverfasser:	Evans, John T, Kerner, Jr., Robert L
Format:	Artikel
Sprache:	eng
Schlagworte:	Appetite Brain research Cardiovascular disease Controlled substances Drug dosages FDA approval Fen-phen diet Fenfluramine Health aspects Heart Litigation Media coverage Metabolism Nervous system Obesity Pathophysiology Pharmacology Phentermine Prescription drugs Products liability Psychosis Pulmonary hypertension Serotonin Weight control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!